|
WO2013095965A1
|
|
Stable storage of enveloped viruses in histidine aqueous solution
|
|
MX2009011228A
|
|
Detection her-2/neu protein from non-isolated circulating cancer cells and treatment.
|
|
WO2007121459A2
|
|
Detection of steroid receptors on circulating carcinoma cells and treatment
|
|
MX2008013333A
|
|
Detection of circulating endothelial cells.
|
|
EP2008102A2
|
|
Detection of proteins from circulating neoplastic cells
|
|
AU2006270297A1
|
|
Cancer treatment using viruses, fluoropyrimidines and camptothecins
|
|
AU2005237176A1
|
|
Treatment of neoplasms with viruses
|
|
NZ554550A
|
|
Stable and filterable enveloped virus formulations
|
|
US2008166784A1
|
|
Stable and filterable enveloped virus formulations
|
|
CA2582713A1
|
|
Detection of elevated levels of her-2/neu protein on circulating cancer cells and treatment
|
|
MXPA06012145A
|
|
Cancer treatment using viruses and camptothecins.
|
|
AU2005201079A1
|
|
Treatment of neoplasms with viruses
|
|
CN1780556A
|
|
Treating hepatocellular carcinomas using therapeutic viruses
|
|
NZ543056A
|
|
Newcastle disease virus comprising a plurality of doses for treating a mammalian subject having a tumour
|
|
MXPA05010172A
|
|
Newcastle disease virus administration.
|
|
AU2003287472A8
|
|
Treating carcinoid neoplasms with therapeuthic viruses
|
|
EP2266601A1
|
|
Administration of therapeutic viruses
|
|
WO03090676A2
|
|
Immunogenic agent therapy using plasmapheresis or exchange transfusion
|
|
US2003165465A1
|
|
Treatment of neoplasms with RNA viruses
|
|
AU2002256510B2
|
|
Oncolytic virus therapy
|
